Shomron Ben-Horin Selected Research

6-thioguanylic acid

4/2019	Low 6-thioguanine nucleotide level: Effective in maintaining remission in Chinese patients with Crohn's disease.
11/2018	6-Thioguanine Nucleotide Levels Are Associated With Mucosal Healing in Patients With Crohn's Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shomron Ben-Horin Research Topics

Disease

62	Crohn Disease (Crohn's Disease) 01/2022 - 08/2008
51	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 07/2022 - 09/2009
32	Ulcerative Colitis 12/2022 - 07/2008
18	Inflammation (Inflammations) 01/2022 - 11/2004
7	Necrosis 07/2022 - 11/2007
6	Rheumatoid Arthritis 01/2022 - 11/2007
5	COVID-19 05/2022 - 03/2021
5	Infections 02/2022 - 09/2009
4	Ulcer 01/2021 - 01/2019
4	Fistula 11/2018 - 03/2015
4	Colitis 11/2016 - 11/2004
3	Pathologic Constriction (Stenosis) 05/2021 - 12/2017
3	Celiac Disease (Celiac Sprue) 01/2019 - 04/2006
2	Rheumatic Diseases (Rheumatism) 05/2022 - 01/2022
2	Abdominal Pain (Pain, Abdominal) 09/2021 - 07/2008
2	Tachycardia (Tachyarrhythmias) 01/2021 - 11/2020
2	Neoplasms (Cancer) 01/2020 - 01/2006
2	Abscess 04/2019 - 08/2014
2	Proctitis 11/2018 - 01/2010
2	Diarrhea 09/2009 - 07/2008
2	Fever (Fevers) 07/2008 - 05/2002
1	Vitamin D Deficiency 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Carcinogenesis 01/2022
1	Adenocarcinoma 01/2022
1	Cross Infection (Nosocomial Infection) 01/2022
1	Fatigue 09/2021
1	Body Weight (Weight, Body) 01/2021
1	Thrombocytosis (Thrombocythemia) 01/2021
1	Hernia (Hernias) 01/2021
1	Leukocytosis (Pleocytosis) 01/2021
1	Anemia 11/2020
1	Hyponatremia 11/2020
1	Arthralgia (Joint Pain) 06/2020
1	Pneumonia (Pneumonitis) 01/2020
1	Bronchiectasis 01/2020
1	Lymphoma (Lymphomas) 01/2020
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2020
1	Disease Progression 01/2019
1	Dysbiosis 01/2019

Drug/Important Bio-Agent (IBA)

33	Infliximab (Remicade)FDA Link 07/2022 - 12/2011
19	Capsules (Microcapsules)IBA 05/2021 - 09/2015
18	Pharmaceutical PreparationsIBA 07/2022 - 11/2012
17	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 11/2004
17	AntibodiesIBA 12/2021 - 12/2012
12	vedolizumabIBA 01/2022 - 09/2014
9	Biological ProductsIBA 01/2022 - 10/2010
8	Immunologic Factors (Immunomodulators)IBA 02/2022 - 09/2009
7	Adalimumab (Humira)FDA Link 07/2022 - 11/2014
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2015
7	Tumor Necrosis Factor InhibitorsIBA 01/2021 - 10/2010
6	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2022 - 07/2008
6	CytokinesIBA 05/2019 - 11/2004
4	Ustekinumab (CNTO 1275)FDA Link 01/2021 - 01/2019
4	Biosimilar PharmaceuticalsIBA 01/2021 - 12/2016
4	CT-P13IBA 01/2021 - 01/2015
4	Monoclonal AntibodiesIBA 11/2019 - 12/2016
4	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2019 - 03/2015
3	Mesalamine (Mesalazine)FDA LinkGeneric 12/2022 - 08/2015
3	C-Reactive ProteinIBA 01/2021 - 03/2015
3	IntegrinsIBA 01/2018 - 01/2017
3	Anti-Bacterial Agents (Antibiotics)IBA 07/2011 - 03/2002
2	VaccinesIBA 01/2022 - 11/2018
2	Contrast MediaIBA 04/2019 - 09/2016
2	6-thioguanylic acidIBA 04/2019 - 11/2018
2	NucleotidesIBA 11/2018 - 11/2018
2	Thioguanine (Tioguanine)FDA Link 11/2018 - 11/2018
2	2-mercaptopurineIBA 11/2018 - 07/2013
2	Azathioprine (Imuran)FDA LinkGeneric 03/2018 - 12/2014
2	AntigensIBA 02/2015 - 04/2006
2	Antiviral Agents (Antivirals)IBA 03/2014 - 02/2013
2	GliadinIBA 11/2013 - 04/2006
1	Immunosuppressive Agents (Immunosuppressants)IBA 02/2022
1	Coffee FDA Link 01/2022
1	tofacitinibIBA 01/2022
1	mRNA VaccinesIBA 01/2022
1	Syndecan-1 (Syndecan 1)IBA 01/2022
1	AlbuminsIBA 01/2021
1	SolutionsIBA 01/2021
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2021
1	Alkaline PhosphataseIBA 11/2020
1	Opioid Analgesics (Opioids)IBA 01/2020
1	Anti-Idiotypic AntibodiesIBA 01/2020
1	Messenger RNA (mRNA)IBA 05/2019
1	contrast agent BR1IBA 04/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Interferon-gamma (Interferon, gamma)IBA 01/2019
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2019
1	Protein Glutamine gamma Glutamyltransferase 2IBA 01/2019
1	Matrix Metalloproteinases (MMPs)IBA 01/2019
1	Muromonab-CD3 (Muromonab CD3)FDA Link 11/2018

Therapy/Procedure

34	Therapeutics 07/2022 - 11/2007
4	Remission Induction 01/2022 - 01/2017
3	Colectomy 01/2017 - 09/2009
2	Length of Stay 01/2021 - 03/2002
1	Immunomodulation 02/2022
1	Tonsillectomy 01/2022
1	Duration of Therapy 01/2022
1	Restorative Proctocolectomy 07/2020
1	Biological Therapy 01/2020